Cargando…
Statins Improve Clinical Outcome After Non-aneurysmal Subarachnoid Hemorrhage: A Translational Insight From a Systematic Review of Experimental Studies
The efficacy of statin-treatment in aneurysmal subarachnoid hemorrhage (SAH) remains controversial. We aimed to investigate the effects of statin-treatment in non-aneurysmal (na)SAH in accordance with animal research data illustrating the pathophysiology of naSAH. We systematically searched PubMed u...
Autores principales: | Kashefiolasl, Sepide, Wagner, Marlies, Brawanski, Nina, Seifert, Volker, Wanderer, Stefan, Andereggen, Lukas, Konczalla, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160298/ https://www.ncbi.nlm.nih.gov/pubmed/34054685 http://dx.doi.org/10.3389/fneur.2021.620096 |
Ejemplares similares
-
Impact of COVID-19 Pandemic on Treatment Management and Clinical Outcome of Aneurysmal Subarachnoid Hemorrhage – A Single-Center Experience
por: Kashefiolasl, Sepide, et al.
Publicado: (2022) -
Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?
por: Wanderer, Stefan, et al.
Publicado: (2022) -
The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage
por: Wanderer, Stefan, et al.
Publicado: (2020) -
Does aneurysm side influence the infarction side and patients´ outcome after subarachnoid hemorrhage?
por: Brawanski, Nina, et al.
Publicado: (2019) -
Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
por: Rhim, Ha-Young, et al.
Publicado: (2021)